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Pachyonychia congenita type 2 (PC-2), also known as 17 (K17) gene and in its expression partner keratin 6b.
In this report, we describe a novel germline mutationJackson-Lawler type PC, is an autosomal dominant
disorder characterized by hypertrophic nail dystrophy in K17, M88T, in a family with PC-2. Key words: K17/
pachyonychia congenita. Journal of Investigative Dermatologyassociated with focal keratoderma and multiple pilo-
sebaceous cysts. It has been demonstrated that PC-2 113:848–850, 1999
is associated with germline mutations in the keratin
K exhibiting PC-2 phenotype was mapped within the type I keratingene cluster on chromosome 17q12–21 (Munro et al, 1994).Subsequently, a germline mutation in keratin 17 gene (K17) wasidentified in this kindred (McLean et al, 1995). Soon after, K17gene mutations were found in other families with PC-2 (Smitheratins are intermediate filament proteins that arecoexpressed as specific type I and type II keratinpairs. Together, these pairs are expressed in epithelialtissues at different stages of development and differen-tiation. Keratins possess a 310 amino acid residue
α-helical rod domain, flanked by nonhelical amino head and et al, 1997), as well as in families presenting with steatocystomas in
the absence of nail changes, also known clinically as steatocystomacarboxy tail domains. The rod domain consists of four segments
referred to as helix 1A, 1B, 2A, and 2B. The sequences, at the multiplex (SM) (Covello et al, 1998).
K17 is a type I keratin expressed in the outer root sheath of hairbeginning of the helix 1A and at the end of the helix 2B, are
highly conserved and are the most critical for the assembly of the follicle, sebaceous gland, nail bed, as well as other appendages
(Troyanovsky et al, 1989, 1992). Until recently, the expression10 nm keratin filaments in vivo and in vitro. Therefore, mutations
in these segments can disrupt filament formation and filament partner of K17 had been unknown. Smith et al demonstrated
colocalization of K17 with keratin 6b, and described a family withstability (Letai et al, 1992; Fuchs and Weber, 1994; Corden and
McLean, 1996). PC-2 in whom a keratin 6b mutation was identified (Smith et al,
1998). To date, 12 families with PC-2 or SM phenotype werePachyonychia congenita (PC) is a group of autosomal dominantly
inherited diseases characterized by nail dystrophy and by varying shown to exhibit germline mutations in the K17 gene (McLean
et al, 1995; Smith et al, 1997; Covello et al, 1998; Fujimoto et al,features of ectodermal dysplasia. Based on the clinical phenotype,
several different classifications exist. There are two major subgroups 1998). All of the mutations have been in exon 1, which encodes
the highly conserved sequences of helix 1A. In this report, weof the disease. Jadassohn-Lewandowsky type PC (PC-1) presents
with nail dystrophy accompanied by focal palmoplantar kerato- describe a novel heterozygous missense mutation in the helix
initiation domain of the K17 gene in a family with the PC-2derma, follicular keratoses, and oral leukokeratosis (Gorlin et al,
1976). PC-1 is associated with mutations in the keratin 16 gene phenotype.
(McLean et al, 1995), or its expression partner keratin 6a (Bowden
MATERIALS AND METHODSet al, 1995). By contrast, Jackson-Lawler type PC (PC-2) is
characterized by the presence of nail dystrophy and cysts arising Genomic DNA was extracted from whole blood using a QIAamp Blood
Maxi Kit (Qiagen, Valencia, CA). Exon 1 of the K17 gene was amplifiedfrom the hair follicle infundibulum (epidermoid or infundibular
by PCR with primers specific for the K17 gene, which do not amplifycysts), and those arising from the sebaceous duct epithelium
either of the two pseudogenes, as described previously (McLean et al,(eruptive vellus hair cysts and steatocystomas) (Jackson and Lawler,
1995). For mutation detection, PCR products were sequenced using an1951). Additional findings in this group include natal teeth, hair
Applied Biosystem 310 automated sequencing system.abnormalities (pili torti), and hidradenitis suppurativa (Moon et al, The K17 mutation, M88T, destroys a restriction site Nla III, which was
1994). Linkage analysis of a single family with 25 affected members used to confirm the mutation in the affected individuals. The PCR
products were digested with with Nla III at 37°C for 2 h and analyzed on
a 2% agarose/TBE mini gel.
RESULTSManuscript received June 18, 1999; revised July 29, 1999; accepted for
publication August 5, 1999. Clinical data The pedigree is illustrated in Fig 1(b). The probandCorrespondence: Dr. Monica Peacocke, Department of Dermatology,
(SD1–1) is a 27-y-old female of Caribbean origin, who developedColumbia University, 630 West 168th Street, VC-1526, New York,
thick dystrophic nails of the fingers and toes during the childhoodNY 10032. E-mail: mp231@columbia.edu
period. In the second decade of life, she developed numerous cystsAbbreviations: K17, keratin 17; PC, pachyonychia congenita; SM,
steatocystoma multiplex. on the trunk as well as hidradenitis suppurativa in both axillae.
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Figure 1. Clinical data, sequence analysis of
exon 1 of the keratin 17 gene, and confirmation
of the mutation by restriction endonuclease
digestion. Hypertrophic finger nails of patient SD1–
2. Pedigree of the family. A wild-type sequence and
sequences of the affected individuals, SD1–1 and
SD1–2. The Nla III digestion of the exon 1 cuts the
978 bp PCR product into 467, 411, and 100 bp
fragments on the mutant allele (lanes 1 and 2
correspond to SD1–1 and SD1–2, respectively),
whereas three cuts are observed on the wild-type
allele resulting in 411, 261, 206, and 100 bp fragments
(lanes 3 and 4 correspond to SD1–3 and a control
sample, respectively).
Table I. Summary of keratin 17 mutations in families with pachyonychia congenita type 2 and steatocystoma multiplex
Exon/
# Phenotype Mutation Predicted effect K17 domain # of families Citation
1 PC-2 422 A.G N 92 D 1/IA 1 McLean
2 PC-2 423 A.G N 92 S 1/IA 6 Smith, Covello, Fujimoto
3 PC-2 440 T.G Y 98 D 1/IA 1 Smith
4 PC-2 or SM 422 A.C N 92 H 1/IA 1 Smith
5 PC-2 or SM 429 G.A R 94 H 1/IA 1 Smith
6 PC-2 428 C.T R 94 C 1/IA 1 Covello
7 SM 428 C.T R 94 C 1/IA 1 Covello
Skin biopsies of the cysts showed a variety of histologic findings K17 have been demonstrated in both disorders. Moreover, indi-
viduals exhibiting both the clinical phenotypes of PC-2 and SM,including epidermoid cyst, eruptive vellus hair cyst, and steato-
cystoma. The proband’s 5-y-old son (SD1–2) was born with natal within the same family associated with a single K17 mutation,
R94C, has also been described (Covello et al, 1998). These datateeth and has similar cutaneous findings including thick dystrophic
nails (Fig 1a), follicular keratosis, cysts, and hidradenitis, all of support the notion that, at least at the genetic level, PC-2 and SM
are similar entities.which are characteristic of pachyonychia congenita type 2. Neither
the proband nor her son has had a keratoderma, leukokeratosis of We have identified a novel missense mutation (M88T) in the
1A subdomain of K17 gene in a family with PC-2. The M88Tthe tongue, or hair abnormalities.
substitution is located within the first 15 residues of the helix
Mutation detection and confirmation Direct sequencing of initiation motif that is highly conserved among all intermediate
the functional K17 gene with primers flanking exon 1 showed a filaments. This substitution would be expected to lead to a distortion
T to C transition at nucleotide 411 (ATG→ACG). This transition of the alpha-helical structure at the beginning of the 1A domain.
results in the replacement of methionine by threonine (M88T) To date, 12 mutations in K17 gene have been identified in families
(Fig 1c). This heterozygous missense mutation was identified in with either the PC-2 or the SM phenotype. As indicated in
both affected individuals (SD1–1 and SD1–2), but not in the Table I, all of these mutations are heterozygous missense mutations,
proband’s unaffected mother (SD1–3). Unfortunately, the proband’s located in the helix initiation domain (1A) of K17. The clustering
unaffected father was not available for testing. This sequence of the mutations in the helix initiation motif is not surprising,
alteration destroys a restriction site, Nla III, which was used to because this area is highly conserved and even subtle amino acid
confirm the mutation in the affected family members (Fig 1d). changes are likely to disrupt intermediate filament formation
Additionally, the mutation was excluded from 50 unrelated controls and assembly.
by direct sequencing of exon 1.
DISCUSSION
The authors gratefully acknowledge the generous participation of the family.
Until recently, PC-2 and SM have been considered as separate Supported in part by grants from the National Cancer Institute (RO-1 CA-66693
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antly with nail dystrophy accompanied by focal keratoderma and 00694 to M.P.), and the National Institute of Arthritis and Musculoskeletal and
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ectodermal dysplasias, whereas SM is characterized by multiple R. Bickers).
steatocystomas as the only clinical finding. Recently, mutations in
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